|
1
|
Kopelman PG: Obesity as a medical problem.
Nature. 404:635–643. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kahn BB and Flier JS: Obesity and insulin
resistance. J Clin Invest. 106:473–481. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Keller M, Hopp L, Liu X, Wohland T, Rohde
K, Cancello R, Klös M, Bacos K, Kern M, Eichelmann F, et al:
Genome-wide DNA promoter methylation and transcriptome analysis in
human adipose tissue unravels novel candidate genes for obesity.
Mol Metab. 6:86–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Otto TC and Lane MD: Adipose development:
From stem cell to adipocyte. Crit Rev Biochem Mol Biol. 40:229–242.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Helder MN, Knippenberg M, Klein-Nulend J
and Wuisman PI: Stem cells from adipose tissue allow challenging
new concepts for regenerative medicine. Tissue Eng. 13:1799–1808.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barry F, Boynton RE, Liu B and Murphy JM:
Chondrogenic differentiation of mesenchymal stem cells from bone
marrow: Differentiation-dependent gene expression of matrix
components. Exp Cell Res. 268:189–200. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arinzeh TL: Mesenchymal stem cells for
bone repair: Preclinical studies and potential orthopedic
applications. Foot Ankle Clin. 10:651–665. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Subash-Babu P and Alshatwi AA: Aloe-emodin
inhibits adipocyte differentiation and maturation during in vitro
human mesenchymal stem cell adipogenesis. J Biochem Mol Toxicol.
26:291–300. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
del Valle I, Rudloff S, Carles A, Li Y,
Liszewska E, Vogt R and Kemler R: E-cadherin is required for the
proper activation of the Lifr/Gp130 signaling pathway in mouse
embryonic stem cells. Development. 140:1684–1692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pan W, Cain C, Yu Y and Kastin AJ:
Receptor-mediated transport of LIF across blood-spinal cord barrier
is upregulated after spinal cord injury. J Neuroimmunol.
174:119–125. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Plun-Favreau H, Perret D, Diveu C, Froger
J, Chevalier S, Lelièvre E, Gascan H and Chabbert M: Leukemia
inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share
structural binding determinants in the immunoglobulin-like domain
of LIF receptor. J Biol Chem. 278:27169–27179. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
White UA and Stephens JM: Neuropoietin
activates STAT3 Independent of LIFR activation in adipocytes.
Biochem Biophys Res Commun. 395:48–50. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morton SD, Cadamuro M, Brivio S, Vismara
M, Stecca T, Massani M, Bassi N, Furlanetto A, Joplin RE, Floreani
A, et al: Leukemia inhibitory factor protects cholangiocarcinoma
cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1
activation. Oncotarget. 6:26052–26064. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ikeda S, Itoh S, Yamamoto Y, Matsushita K,
Naruse H and Hayashi M: Developmental stage-dependent effects of
leukemia inhibitory factor on adipocyte differentiation of murine
bone marrow stromal cells. Cell Biochem Biophys. 74:11–17. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aubert J, Dessolin S, Belmonte N, Li M,
McKenzie FR, Staccini L, Villageois P, Barhanin B, Vernallis A,
Smith AG, et al: Leukemia inhibitory factor and its receptor
promote adipocyte differentiation via the mitogen-activated protein
kinase cascade. J Biol Chem. 274:24965–24972. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fernyhough ME, Hausman GJ, Guan LL, Okine
E, Moore SS and Dodson MV: Mature adipocytes may be a source of
stem cells for tissue engineering. Biochem Biophys Res Commun.
368:455–457. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Yang Y, Yan R, Xu X, Gao L, Mei J,
Liu J, Wang X, Zhang J, Wu P, et al: miR-377-3p regulates
adipogenic differentiation of human bone marrow mesenchymal stem
cells by regulating LIFR. Mol Cell Biochem. 449:295–303. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Farmer SR: Transcriptional control of
adipocyte formation. Cell Metab. 4:263–273. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kudo M, Sugawara A, Uruno A, Takeuchi K
and Ito S: Transcription suppression of peroxisome
proliferator-activated receptor gamma2 gene expression by tumor
necrosis factor alpha via an inhibition of CCAAT/enhancer-binding
protein delta during the early stage ofadipocyte differentiation.
Endocrinology. 145:4948–4956. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rosen ED, Walkey CJ, Puigserver P and
Spiegelman BM: Transcriptional regulation of adipogenesis. Genes
Dev. 14:1293–1307. 2000.PubMed/NCBI
|
|
23
|
Zhang J, Huang Y, Shao H, Bi Q, Chen J and
Ye Z: Grape seed procyanidin B2 inhibits adipogenesis of 3T3-L1
cells by targeting peroxisome proliferator-activated receptor γ
with miR-483-5p involved mechanism. Biomed Pharmacother.
86:292–296. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Floyd ZE and Stephens JM: Controlling a
master switch of adipocyte development and insulin sensitivity:
Covalent modifications of PPARγ. Biochim Biophys Acta.
1822:1090–1095. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Furuhashi M, Tuncman G, Gorgun CZ,
Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S,
Linton MF, et al: Treatment of diabetes and atherosclerosis by
inhibiting fatty-acid-binding protein FABP4. Nature. 447:959–965.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hwang CS, Mandrup S, MacDougald OA, Geiman
DE and Lane MD: Transcriptional activation of the mouse obese (ob)
gene by CCAAT/enhancer binding protein alpha. Proc Natl Acad Sci
USA. 93:873–877. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oskowitz AZ, Lu J, Penfornis P, Ylostalo
J, McBride J, Flemington EK, Prockop DJ and Pochampally R: Human
multipotent stromal cells from bone marrow and microRNA: Regulation
of differentiationand leukemia inhibitory factor expression. Proc
Natl Acad Sci USA. 105:18372–18377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hogan JC and Stephens JM: Effects of
leukemia inhibitory factor on 3T3-L1 adipocytes. J Endocrinol.
185:485–496. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Margioula-Siarkou C, Prapas Y, Petousis S,
Milias S, Ravanos K, Kalogiannidis I, Mavromatidis G, Haitoglou C,
Prapas N and Rousso D: LIF and LIF-R expression in the endometrium
of fertile and infertile women: A prospective observational
case-control study. Mol Med Rep. 13:4721–4728. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Sun L, Zhao D, Ouyang J and Xiang M:
Aberrant expression of leukemia inhibitory factor receptor (LIFR)
and leukemia inhibitory factor (LIF) is associated with tubal
pregnancy occurrence. Turk J Med Sci. 45:214–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saito M, Asai Y, Imai K, Hiratoko S and
Tanaka K: Connexin30.3 is expressed in mouse embryonic stem cells
and is responsive to leukemia inhibitory factor. Sci Rep.
7:424032017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cherepkova MY, Sineva GS and Pospelov VA:
Leukemia inhibitory factor (LIF) withdrawal activates mTOR
signaling pathway in mouse embryonic stem cells through the
MEK/ERK/TSC2 pathway. Cell Death Dis. 7:e20502016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng HC, Liu SW, Li W, Zhao XF, Zhao X,
Cheng M, Qiu L and Ma J: Arsenic trioxide regulates adipogenic and
osteogenic differentiation in bone marrow MSCs of aplastic anemia
patients through BMP4 gene. Acta Biochim Biophys Sin (Shanghai).
47:673–679. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lecourt S, Vanneaux V, Leblanc T, Leroux
G, Ternaux B, Benbunan M, Chomienne C, Baruchel A, Marolleau JP,
Gluckman E, et al: Bone marrow microenvironment in fanconi anemia:
A prospective functional study in a cohort of fanconi anemia
patients. Stem Cells Dev. 19:203–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Natesh K, Bhosale D, Desai A, Chandrika G,
Pujari R, Jagtap J, Chugh A, Ranade D and Shastry P: Oncostatin-M
differentially regulates mesenchymal and proneural signature genes
in gliomas via STAT3 signaling. Neoplasia. 17:225–237. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wagener EM, Aurich M, Aparicio-Siegmund S,
Floss DM, Garbers C, Breusing K, Rabe B, Schwanbeck R, Grötzinger
J, Rose-John S and Scheller J: The amino acid exchange R28E in
ciliaryneurotrophic factor (CNTF) abrogates interleukin-6
receptor-dependent but retains CNTF receptor-dependent signaling
via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor
(LIFR). J Biol Chem. 289:18442–184450. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu GX, Zhu JC, Chen XY, Zhu AZ, Liu CC,
Lai Q and Chen ST: Inhibition of adipogenic differentiation of bone
marrow mesenchymal stem cells by erythropoietin via activating ERK
and P38 MAPK. Genet Mol Res. 14:6968–6977. 2015. View Article : Google Scholar : PubMed/NCBI
|
